| Regimen | Duration of therapy (month range) | Best response | Reason for stopping |
| Bortezomib/thalidomide/cyclophosphamide/dexamethasone (VTCD) | 5 (May-Oct 2020) | CR | Started ASCT |
| ASCT | Oct 2020 | CR | Started maintenance |
| Lenalidomide | 5 (Oct 2020-Mar 2021) | CR | PD |
| Daratumumab/ixazomib/dexamethasone (DId) | 1 (Mar-Apr 2021) | PD | PD |
| liposome doxorubicin/pomalidomide/ixazomib/dexamethasone (PIDd) | 2 (Apr-Jun 2021) | PD | PD |
| Selinexor/pomalidomide/dexamethasone (XPd) | 1 (Jun-Jul 2021) | PD | PCL |
| Selinexor/carfizomib/pomalidonide/dexamethasone (XKPd) | 4 (Jul-Nov 2021) | CR | Died |